BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15885541)

  • 21. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
    Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
    Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
    Horn B; Reiss U; Matthay K; McMillan A; Cowan M
    Bone Marrow Transplant; 2002 Mar; 29(5):409-15. PubMed ID: 11919731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transplant infections: single center experience from the developing world.
    Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infections in children undergoing allogeneic bone marrow transplantation in India.
    George B; Mathews V; Viswabandya A; Srivastava A; Chandy M
    Pediatr Transplant; 2006 Feb; 10(1):48-54. PubMed ID: 16499587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
    Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children.
    Machatschek J; Duda J; Matthay K; Cowan M; Horn B
    Bone Marrow Transplant; 2003 Oct; 32(7):687-93. PubMed ID: 13130316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
    Kohno K; Nagafuji K; Tsukamoto H; Horiuchi T; Takase K; Aoki K; Henzan H; Kamezaki K; Takenaka K; Miyamoto T; Teshima T; Harada M; Akashi K
    Transpl Infect Dis; 2009 Aug; 11(4):318-23. PubMed ID: 19453993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer.
    Barton T; Collis T; Stadtmauer E; Schuster M
    Clin Infect Dis; 2001 Feb; 32(3):391-5. PubMed ID: 11170946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.
    Reich G; Mapara MY; Reichardt P; Dörken B; Maschmeyer G
    Bone Marrow Transplant; 2001 Mar; 27(5):525-9. PubMed ID: 11313687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients.
    Zambelli A; Montagna D; Da Prada GA; Maccario R; Zibera C; Moretta A; Ponchio L; Lozza L; Baiardi P; Maserati R; Marone P; Della Cuna GR
    Anticancer Res; 2002; 22(6B):3701-8. PubMed ID: 12552979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High susceptibility to severe infectious complications at reinduction chemotherapy in patients who relapse after stem cell transplantation.
    Iguchi A; Kobayashi R; Sato TZ; Naito H; Shikano T; Ishikawa Y; Kobayashi K
    Transplant Proc; 2010 Jun; 42(5):1857-61. PubMed ID: 20620537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.
    Brown RJ; Rahim H; Wong KE; Cooper RM; Marachelian A; Butturini A; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2013 Dec; 60(12):2012-7. PubMed ID: 23956157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
    Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
    Bone Marrow Transplant; 2007 Dec; 40(11):1055-62. PubMed ID: 17891187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.